ClinicalTrials.gg
CompletedNCT04335838Updated Nov 26, 2024

Age, Traumatic Brain Injury and Injury Severity as Independent Risk Factors for In-Hospital Mortality in Polytrauma Patients.

An observational study in Polytrauma and Traumatic Brain Injury, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-26.

Sponsored by Medical University of Vienna · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

In this study patients who were admitted to our hospital with critical injuries were enrolled retrospectively from January 2012 to December 2015. Patients with an ISS>16 points, an AIS >3 in one body region and at least 2 different body regions affected were included. Possible prognostic factors were evaluated.

02

Conditions studied

  • Polytrauma
  • Traumatic Brain Injury

Keywords

  • prognostic factors
  • New Berlin Definition
  • Polytrauma
03

In context

Multiple Trauma

139 studies on the registry are indexed under Multiple Trauma; 32 are open to participants now.

This study's enrollment of 400 is above the median of 200 across 84 observational studies indexed under Multiple Trauma.

Browse Multiple Trauma studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,109 studies on the registry; 184 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Retrospective analysis of polytrauma patients.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ISS >16 points
  • AIS >3 in one body region
  • at least 2 body regions affected

Exclusion criteria

Exclusion Criteria:

  • patients younger than 18 years of age
  • isolated traumatic brain injury
  • minor injuries (AIS \<3 or ISS \<16 points)
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
400 participants (actual)
Patient registry
No

Groups and cohorts

  • Polytrauma Patients

    Patients with an ISS \>16 points, an AIS \>3 in one body region and at least 2 different body regions affected were included.

    Other: retrospective analysis

Interventions

  • Otherretrospective analysis

    The investigators retrospectively analyzed the outcome and possible prognostic factors in polytrauma patients.

06

What researchers measure

Primary outcomes

  1. In-hospital mortality in polytrauma patients.

    Time frame: January 1, 2012 to December 31, 2015

Secondary outcomes

  1. Possible prognostic factors influencing the outcome of polytrauma patients.

    Evaluation of concomitant traumatic brain injury, resuscitation, injury severity and trauma mechanisms in polytrauma patients.

    Time frame: Januar 1, 2012 to December 31, 2015

07

Study locations

1 site
  • Medical University of Vienna, Department of Traumatology
    Vienna, 1090, Austria
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2012 to primary completion in Dec 2015, 47 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2020
First posted
Apr 6, 2020
StartActual
Jan 2012
Primary completionActual
Dec 2015
CompletionActual
Dec 2015
Last update
Nov 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04335838
Responsible party
Dr. Valerie Weihs (Principle Investigator, Medical University of Vienna) — Principal investigator
First posted
Apr 6, 2020
Start date
Jan 2012
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Nov 26, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion